izpis_h1_title_alt

Isolation and in vitro characterization of novel S. epidermidis phages for therapeutic applications
ID Štrancar, Vida (Author), ID Marušić, Monika (Author), ID Tušar, Jasmina (Author), ID Praček, Neža (Author), ID Kolenc, Marko (Author), ID Šuster, Katja (Author), ID Horvat, Simon (Author), ID Janež, Nikolaja (Author), ID Peterka, Matjaž (Author)

.pdfPDF - Presentation file, Download (3,99 MB)
MD5: F5F5622794EDDD9998ABE4B3F65E70A6
URLURL - Source URL, Visit https://www.frontiersin.org/articles/10.3389/fcimb.2023.1169135/full This link opens in a new window

Abstract
S. epidermidis is an important opportunistic pathogen causing chronic prosthetic joint infections associated with biofilm growth. Increased tolerance to antibiotic therapy often requires prolonged treatment or revision surgery. Phage therapy is currently used as compassionate use therapy and continues to be evaluated for its viability as adjunctive therapy to antibiotic treatment or as an alternative treatment for infections caused by S. epidermidis to prevent relapses. In the present study, we report the isolation and in vitro characterization of three novel lytic S. epidermidis phages. Their genome content analysis indicated the absence of antibiotic resistance genes and virulence factors. Detailed investigation of the phage preparation indicated the absence of any prophage-related contamination and demonstrated the importance of selecting appropriate hosts for phage development from the outset. The isolated phages infect a high proportion of clinically relevant S. epidermidis strains and several other coagulase-negative species growing both in planktonic culture and as a biofilm. Clinical strains differing in their biofilm phenotype and antibiotic resistance profile were selected to further identify possible mechanisms behind increased tolerance to isolated phages.

Language:English
Keywords:therapeutic phages, phage safety and efficacy, prosthetic joint infections, biofilms, Staphylococcus epidemidis
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:BF - Biotechnical Faculty
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:12 str.
Numbering:Vol. 13, art. 1169135
PID:20.500.12556/RUL-147013 This link opens in a new window
UDC:579
ISSN on article:2235-2988
DOI:10.3389/fcimb.2023.1169135 This link opens in a new window
COBISS.SI-ID:153323523 This link opens in a new window
Publication date in RUL:20.06.2023
Views:340
Downloads:61
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Frontiers in cellular and infection microbiology
Shortened title:Front. cell. infect. microbiol.
Publisher:Frontiers Media
ISSN:2235-2988
COBISS.SI-ID:523093785 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:mikrobiologija, S. epidermidis, antibiotiki, rezistenca, fagi, terapija

Projects

Funder:ARRS - Slovenian Research Agency
Project number:L3-2620
Name:Razvoj bakteriofagne terapije za zdravljenje ortopedskih okužb, ki jih povzročajo bakterije, odporne na antibiotike

Funder:ARRS - Slovenian Research Agency
Project number:J7-2603
Name:Učinkovitost bakteriofagov za zdravljenje ekstracelularnih in intracelularnih bakterijskih okužb implantatov

Funder:ARRS - Slovenian Research Agency
Project number:P3-0387
Name:Črevesna mikrobiota - vloga v zdravju in pri boleznih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back